Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) Income from Continuing Operations (2020 - 2025)

Bioventus' Income from Continuing Operations history spans 6 years, with the latest figure at 17318000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 2971.97% year-over-year to 17318000.0; the TTM value through Dec 2025 reached 27274000.0, up 157.97%, while the annual FY2025 figure was 27274000.0, 157.97% up from the prior year.
  • Income from Continuing Operations reached 17318000.0 in Q4 2025 per BVS's latest filing, up from 4006000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 24528000.0 in Q2 2021 to a low of 101035000.0 in Q4 2022.
  • Average Income from Continuing Operations over 5 years is 13708400.0, with a median of 6114500.0 recorded in 2024.
  • Peak YoY movement for Income from Continuing Operations: crashed 85808.0% in 2022, then soared 2971.97% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 25000.0 in 2021, then plummeted by 85808.0% to 21477000.0 in 2022, then surged by 64.35% to 7656000.0 in 2023, then soared by 92.12% to 603000.0 in 2024, then skyrocketed by 2971.97% to 17318000.0 in 2025.
  • Per Business Quant, the three most recent readings for BVS's Income from Continuing Operations are 17318000.0 (Q4 2025), 4006000.0 (Q3 2025), and 9272000.0 (Q2 2025).